Please use this identifier to cite or link to this item:
https://open.uns.ac.rs/handle/123456789/32518
Title: | β1-blockade increases maximal apnea duration in elite breath-hold divers | Authors: | Ryan Hoiland Philip Ainslie Anthony Bain David MacLeod Mike Stembridge Ivan Drviš Dennis Madden Otto Barak Douglas MacLeod Željko Dujić |
Keywords: | Adrenergic beta-1 Receptor Antagonists;divers;apnea;Blood Pressure;Breath Holding;Oxygen Consumption;Oxyhemoglobins;Propanolamines;Stroke Volume | Issue Date: | 2017 | Journal: | Journal of Applied Physiology | Abstract: | We hypothesized that the cardioselective β1-adrenoreceptor antagonist esmolol would improve maximal apnea duration in elite breath-hold divers. In elite national-level divers (n = 9), maximal apneas were performed in a randomized and counterbalanced order while receiving either iv esmolol (150 μg.kg-1.min-1) or volume-matched saline (placebo). During apnea, heart rate (ECG), beat-by-beat blood pressure, stroke volume (SV), cardiac output (CO), and total peripheral resistance (TPR) were measured (finger photoplethysmography). Myocardial oxygen consumption (MVO2) was estimated from rate pressure product. Cerebral blood flow through the internal carotid (ICA) and vertebral arteries (VA) was assessed using Duplex ultrasound. Apnea duration improved in the esmolol trial when compared with placebo (356 ± 57 vs. 323 ±61 s, P < 0.01) despite similar end-apnea peripheral oxyhemoglobin saturation (71.8 ± 10.3 vs. 74.9 ± 9.5%, P = 0.10). The HR response to apnea was reduced by esmolol at 10-30% of apnea duration, whereas MAP was unaffected. Esmolol reduced SV (main effect, P < 0.05) and CO (main effect; P < 0.05) and increased TPR (main effect, P < 0.05) throughout apnea. Esmolol also reduced MVO2 throughout apnea (main effect, P < 0.05). Cerebral blood flow through the ICA and VA was unchanged by esmolol at baseline and the last 30 s of apnea; however, global cerebral blood flow was reduced in the esmolol trial at end-apnea (P < 0.05). Our findings demonstrate that, in elite breath-hold divers, apnea breakpoint is improved by β1-blockade, likely owing to an improved total body oxygen sparring through increased centralization of blood volume (∵ TPR) and reduced MVO2. | URI: | https://open.uns.ac.rs/handle/123456789/32518 | ISSN: | 8750-7587 | DOI: | 10.1152/japplphysiol.00127.2016 |
Appears in Collections: | MDF Publikacije/Publications |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.